Using ex vivo culture to assess dynamic phenotype changes in human prostate macrophages following exposure to therapeutic drugs

被引:8
作者
Boibessot, Clovis [1 ,2 ]
Joncas, France-Helene [1 ,2 ]
Park, Aerin [1 ,2 ]
Berrehail, Zohra [1 ,2 ]
Pelletier, Jean-Francois [1 ,2 ]
Gris, Typhaine [1 ,2 ]
Bergeron, Alain [1 ,2 ,3 ]
Toren, Paul [1 ,2 ,3 ]
机构
[1] Univ Laval, CHU Quebec, Ctr Rech, Lab Urooncol Expt,Axe Oncol, 10 McMahon,Rm 0877, Quebec City, PQ G1R 3S1, Canada
[2] Univ Laval, Ctr Rech Sur Canc, Quebec City, PQ, Canada
[3] Univ Laval, Dept Chirurg, Quebec City, PQ, Canada
关键词
TUMOR-ASSOCIATED MACROPHAGES; CANCER; PROGRESSION; TISSUE; MODEL;
D O I
10.1038/s41598-021-98903-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Within the prostate tumor microenvironment (TME) there are complex multi-faceted and dynamic communication occurring between cancer cells and immune cells. Macrophages are key cells which infiltrate and surround tumor cells and are recognized to significantly contribute to tumor resistance and metastases. Our understanding of their function in the TME is commonly based on in vitro and in vivo models, with limited research to confirm these model observations in human prostates. Macrophage infiltration was evaluated within the TME of human prostates after 72 h culture of fresh biopsies samples in the presence of control or enzalutamide. In addition to immunohistochemistry, an optimized protocol for multi-parametric evaluation of cellular surface markers was developed using flow cytometry. Flow cytometry parameters were compared to clinicopathological features. Immunohistochemistry staining for 19 patients with paired samples suggested enzalutamide increased the expression of CD163 relative to CD68 staining. Techniques to validate these results using flow cytometry of dissociated biopsies after 72 h of culture are described. In a second cohort of patients with Gleason grade group >= 3 prostate cancer, global macrophage expression of CD163 was unchanged with enzalutamide treatment. However, exploratory analyses of our results using multi-parametric flow cytometry for multiple immunosuppressive macrophage markers suggest subgroup changes as well as novel associations between circulating biomarkers like the neutrophil to lymphocyte ratio (NLR) and immune cell phenotype composition in the prostate TME. Further, we observed an association between B7-H3 expressing tumor-associated macrophages and the presence of intraductal carcinoma. The use of flow cytometry to evaluate ex vivo cultured prostate biopsies fills an important gap in our ability to understand the immune cell composition of the prostate TME. Our results highlight novel associations for further investigation.
引用
收藏
页数:10
相关论文
共 31 条
  • [1] TAMeless traitors: macrophages in cancer progression and metastasis
    Aras, Shweta
    Zaidi, M. Raza
    [J]. BRITISH JOURNAL OF CANCER, 2017, 117 (11) : 1583 - 1591
  • [2] Mechanisms and Approaches for Overcoming enzalutamide Resistance in Prostate Cancer
    Ark, Alexandra Vander
    Cao, Jingchen
    Li, Xiaohong
    [J]. FRONTIERS IN ONCOLOGY, 2018, 8
  • [3] The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies
    Bingle, L
    Brown, NJ
    Lewis, CE
    [J]. JOURNAL OF PATHOLOGY, 2002, 196 (03) : 254 - 265
  • [4] Projected estimates of cancer in Canada in 2020
    Brenner, Darren R.
    Weir, Hannah K.
    Demers, Alain A.
    Ellison, Larry F.
    Louzado, Cheryl
    Shaw, Amanda
    Turner, Donna
    Woods, Ryan R.
    Smith, Leah M.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (09) : E199 - E205
  • [5] Prognostic role of tumour-associated macrophages and macrophage scavenger receptor 1 in prostate cancer: a systematic review and meta-analysis
    Cao, Jian
    Liu, Jun
    Xu, Ran
    Zhu, Xuan
    Zhao, Xiaokun
    Qian, Bin-Zhi
    [J]. ONCOTARGET, 2017, 8 (47) : 83261 - 83269
  • [6] Ex vivo culture of human prostate tissue and drug development
    Centenera, Margaret M.
    Raj, Ganesh V.
    Knudsen, Karen E.
    Tilley, Wayne D.
    Butler, Lisa M.
    [J]. NATURE REVIEWS UROLOGY, 2013, 10 (08) : 483 - 487
  • [7] Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer
    Conteduca, Vincenza
    Crabb, Simon J.
    Jones, Robert J.
    Caffo, Orazio
    Elliott, Tony
    Scarpi, Emanuela
    Fabbri, Paolo
    Derosa, Lisa
    Massari, Francesco
    Numico, Gianmauro
    Zarif, Sunnya
    Hanna, Catherine
    Maines, Francesca
    Joyce, Helen
    Lolli, Cristian
    De Giorgi, Ugo
    [J]. PLOS ONE, 2016, 11 (07):
  • [8] Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence
    Coutinho, Isabel
    Day, Tanya K.
    Tilley, Wayne D.
    Selth, Luke A.
    [J]. ENDOCRINE-RELATED CANCER, 2016, 23 (12) : T179 - T197
  • [9] Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
    Davis, Ian D.
    Martin, Andrew J.
    Stockler, Martin R.
    Begbie, Stephen
    Chi, Kim N.
    Chowdhury, Simon
    Coskinas, Xanthi
    Frydenberg, Mark
    Hague, Wendy E.
    Horvath, Lisa G.
    Joshua, Anthony M.
    Lawrence, Nicola J.
    Marx, Gavin
    McCaffrey, John
    McDermott, Ray
    McJannett, Margaret
    North, Scott A.
    Parnis, Francis
    Parulekar, Wendy
    Pook, David W.
    Reaume, M. Neil
    Sandhu, Shahneen K.
    Tan, Alvin
    Tan, T. Hsiang
    Thomson, Alastair
    Tu, Emily
    Vera-Badillo, Francisco
    Williams, Scott G.
    Yip, Sonia
    Zhang, Alison Y.
    Zielinski, Robert R.
    Sweeney, Christopher J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (02) : 121 - 131
  • [10] A comparison of flow cytometry and immunohistochemistry in human colorectal cancers
    Diederichsen, ACP
    Hansen, TP
    Nielsen, O
    Fenger, C
    Jensenius, JC
    Christensen, PB
    Kristensen, T
    Zeuthen, J
    [J]. APMIS, 1998, 106 (05) : 562 - 570